Click for best price
Molecular Diagnosis Therapy Market Size, Share 2023
The global Molecular Diagnosis and Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Molecular Diagnosis & Therapy provides researchers and healthcare professionals with insights into the latest molecular diagnostic and therapeutic techniques and their use in precision medicine.
This report aims to provide a comprehensive presentation of the global market for Molecular Diagnosis and Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Diagnosis and Therapy. This report contains market size and forecasts of Molecular Diagnosis and Therapy in global, including the following market information:
- Global Molecular Diagnosis and Therapy Market Revenue, 2018-2023, 2024-2032, ($ millions)
- Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
PCR Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Molecular Diagnosis and Therapy include Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, Biom?rieux Sa, Danaher Corporation, Diasorin, Grifols, Hologic and Illumina, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Molecular Diagnosis and Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Molecular Diagnosis and Therapy Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Molecular Diagnosis and Therapy Market Segment Percentages, by Type, 2022 (%)
Global Molecular Diagnosis and Therapy Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Molecular Diagnosis and Therapy Market Segment Percentages, by Application, 2022 (%)
- Diagnostic Laboratories
- Research & Academic Laboratories
Global Molecular Diagnosis and Therapy Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Molecular Diagnosis and Therapy Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Molecular Diagnosis and Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Molecular Diagnosis and Therapy revenues share in global market, 2022 (%)
Key players include:
- Abbott Laboratories
- Agilent Technologies
- Becton, Dickinson and Company
- Biom?rieux Sa
- Danaher Corporation
- Diasorin
- Grifols
- Hologic
- Illumina
- Qiagen
- Roche Diagnostics
- Siemens AG
- Thermo Fisher Scientific
Outline of Major Chapters:
Chapter 1: Introduces the definition of Molecular Diagnosis and Therapy, market overview.
Chapter 2: Global Molecular Diagnosis and Therapy market size in revenue.
Chapter 3: Detailed analysis of Molecular Diagnosis and Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Molecular Diagnosis and Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Molecular Diagnosis and Therapy Market, Global Outlook and Forecast 2023-2032 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
68 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Molecular Diagnosis and Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Molecular Diagnosis and Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Molecular Diagnosis and Therapy Overall Market Size
2.1 Global Molecular Diagnosis and Therapy Market Size: 2022 VS 2032
2.2 Global Molecular Diagnosis and Therapy Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Molecular Diagnosis and Therapy Players in Global Market
3.2 Top Global Molecular Diagnosis and Therapy Companies Ranked by Revenue
3.3 Global Molecular Diagnosis and Therapy Revenue by Companies
3.4 Top 3 and Top 5 Molecular Diagnosis and Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Molecular Diagnosis and Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Molecular Diagnosis and Therapy Players in Global Market
3.6.1 List of Global Tier 1 Molecular Diagnosis and Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Molecular Diagnosis and Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Molecular Diagnosis and Therapy Market Size Markets, 2022 & 2032
4.1.2 PCR
4.1.3 DNA Sequencing
4.1.4 NGS
4.2 By Type - Global Molecular Diagnosis and Therapy Revenue & Forecasts
4.2.1 By Type - Global Molecular Diagnosis and Therapy Revenue, 2018-2023
4.2.2 By Type - Global Molecular Diagnosis and Therapy Revenue, 2024-2032
4.2.3 By Type - Global Molecular Diagnosis and Therapy Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Molecular Diagnosis and Therapy Market Size, 2022 & 2032
5.1.2 Diagnostic Laboratories
5.1.3 Research & Academic Laboratories
5.2 By Application - Global Molecular Diagnosis and Therapy Revenue & Forecasts
5.2.1 By Application - Global Molecular Diagnosis and Therapy Revenue, 2018-2023
5.2.2 By Application - Global Molecular Diagnosis and Therapy Revenue, 2024-2032
5.2.3 By Application - Global Molecular Diagnosis and Therapy Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Molecular Diagnosis and Therapy Market Size, 2022 & 2032
6.2 By Region - Global Molecular Diagnosis and Therapy Revenue & Forecasts
6.2.1 By Region - Global Molecular Diagnosis and Therapy Revenue, 2018-2023
6.2.2 By Region - Global Molecular Diagnosis and Therapy Revenue, 2024-2032
6.2.3 By Region - Global Molecular Diagnosis and Therapy Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Molecular Diagnosis and Therapy Revenue, 2018-2032
6.3.2 US Molecular Diagnosis and Therapy Market Size, 2018-2032
6.3.3 Canada Molecular Diagnosis and Therapy Market Size, 2018-2032
6.3.4 Mexico Molecular Diagnosis and Therapy Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Molecular Diagnosis and Therapy Revenue, 2018-2032
6.4.2 Germany Molecular Diagnosis and Therapy Market Size, 2018-2032
6.4.3 France Molecular Diagnosis and Therapy Market Size, 2018-2032
6.4.4 U.K. Molecular Diagnosis and Therapy Market Size, 2018-2032
6.4.5 Italy Molecular Diagnosis and Therapy Market Size, 2018-2032
6.4.6 Russia Molecular Diagnosis and Therapy Market Size, 2018-2032
6.4.7 Nordic Countries Molecular Diagnosis and Therapy Market Size, 2018-2032
6.4.8 Benelux Molecular Diagnosis and Therapy Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Molecular Diagnosis and Therapy Revenue, 2018-2032
6.5.2 China Molecular Diagnosis and Therapy Market Size, 2018-2032
6.5.3 Japan Molecular Diagnosis and Therapy Market Size, 2018-2032
6.5.4 South Korea Molecular Diagnosis and Therapy Market Size, 2018-2032
6.5.5 Southeast Asia Molecular Diagnosis and Therapy Market Size, 2018-2032
6.5.6 India Molecular Diagnosis and Therapy Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Molecular Diagnosis and Therapy Revenue, 2018-2032
6.6.2 Brazil Molecular Diagnosis and Therapy Market Size, 2018-2032
6.6.3 Argentina Molecular Diagnosis and Therapy Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Molecular Diagnosis and Therapy Revenue, 2018-2032
6.7.2 Turkey Molecular Diagnosis and Therapy Market Size, 2018-2032
6.7.3 Israel Molecular Diagnosis and Therapy Market Size, 2018-2032
6.7.4 Saudi Arabia Molecular Diagnosis and Therapy Market Size, 2018-2032
6.7.5 UAE Molecular Diagnosis and Therapy Market Size, 2018-2032
7 Molecular Diagnosis and Therapy Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Molecular Diagnosis and Therapy Major Product Offerings
7.1.4 Abbott Laboratories Molecular Diagnosis and Therapy Revenue in Global Market (2018-2023)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 Agilent Technologies
7.2.1 Agilent Technologies Company Summary
7.2.2 Agilent Technologies Business Overview
7.2.3 Agilent Technologies Molecular Diagnosis and Therapy Major Product Offerings
7.2.4 Agilent Technologies Molecular Diagnosis and Therapy Revenue in Global Market (2018-2023)
7.2.5 Agilent Technologies Key News & Latest Developments
7.3 Becton, Dickinson and Company
7.3.1 Becton, Dickinson and Company Company Summary
7.3.2 Becton, Dickinson and Company Business Overview
7.3.3 Becton, Dickinson and Company Molecular Diagnosis and Therapy Major Product Offerings
7.3.4 Becton, Dickinson and Company Molecular Diagnosis and Therapy Revenue in Global Market (2018-2023)
7.3.5 Becton, Dickinson and Company Key News & Latest Developments
7.4 Biom?rieux Sa
7.4.1 Biom?rieux Sa Company Summary
7.4.2 Biom?rieux Sa Business Overview
7.4.3 Biom?rieux Sa Molecular Diagnosis and Therapy Major Product Offerings
7.4.4 Biom?rieux Sa Molecular Diagnosis and Therapy Revenue in Global Market (2018-2023)
7.4.5 Biom?rieux Sa Key News & Latest Developments
7.5 Danaher Corporation
7.5.1 Danaher Corporation Company Summary
7.5.2 Danaher Corporation Business Overview
7.5.3 Danaher Corporation Molecular Diagnosis and Therapy Major Product Offerings
7.5.4 Danaher Corporation Molecular Diagnosis and Therapy Revenue in Global Market (2018-2023)
7.5.5 Danaher Corporation Key News & Latest Developments
7.6 Diasorin
7.6.1 Diasorin Company Summary
7.6.2 Diasorin Business Overview
7.6.3 Diasorin Molecular Diagnosis and Therapy Major Product Offerings
7.6.4 Diasorin Molecular Diagnosis and Therapy Revenue in Global Market (2018-2023)
7.6.5 Diasorin Key News & Latest Developments
7.7 Grifols
7.7.1 Grifols Company Summary
7.7.2 Grifols Business Overview
7.7.3 Grifols Molecular Diagnosis and Therapy Major Product Offerings
7.7.4 Grifols Molecular Diagnosis and Therapy Revenue in Global Market (2018-2023)
7.7.5 Grifols Key News & Latest Developments
7.8 Hologic
7.8.1 Hologic Company Summary
7.8.2 Hologic Business Overview
7.8.3 Hologic Molecular Diagnosis and Therapy Major Product Offerings
7.8.4 Hologic Molecular Diagnosis and Therapy Revenue in Global Market (2018-2023)
7.8.5 Hologic Key News & Latest Developments
7.9 Illumina
7.9.1 Illumina Company Summary
7.9.2 Illumina Business Overview
7.9.3 Illumina Molecular Diagnosis and Therapy Major Product Offerings
7.9.4 Illumina Molecular Diagnosis and Therapy Revenue in Global Market (2018-2023)
7.9.5 Illumina Key News & Latest Developments
7.10 Qiagen
7.10.1 Qiagen Company Summary
7.10.2 Qiagen Business Overview
7.10.3 Qiagen Molecular Diagnosis and Therapy Major Product Offerings
7.10.4 Qiagen Molecular Diagnosis and Therapy Revenue in Global Market (2018-2023)
7.10.5 Qiagen Key News & Latest Developments
7.11 Roche Diagnostics
7.11.1 Roche Diagnostics Company Summary
7.11.2 Roche Diagnostics Business Overview
7.11.3 Roche Diagnostics Molecular Diagnosis and Therapy Major Product Offerings
7.11.4 Roche Diagnostics Molecular Diagnosis and Therapy Revenue in Global Market (2018-2023)
7.11.5 Roche Diagnostics Key News & Latest Developments
7.12 Siemens AG
7.12.1 Siemens AG Company Summary
7.12.2 Siemens AG Business Overview
7.12.3 Siemens AG Molecular Diagnosis and Therapy Major Product Offerings
7.12.4 Siemens AG Molecular Diagnosis and Therapy Revenue in Global Market (2018-2023)
7.12.5 Siemens AG Key News & Latest Developments
7.13 Thermo Fisher Scientific
7.13.1 Thermo Fisher Scientific Company Summary
7.13.2 Thermo Fisher Scientific Business Overview
7.13.3 Thermo Fisher Scientific Molecular Diagnosis and Therapy Major Product Offerings
7.13.4 Thermo Fisher Scientific Molecular Diagnosis and Therapy Revenue in Global Market (2018-2023)
7.13.5 Thermo Fisher Scientific Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Molecular Diagnosis and Therapy Market Opportunities & Trends in Global Market
Table 2. Molecular Diagnosis and Therapy Market Drivers in Global Market
Table 3. Molecular Diagnosis and Therapy Market Restraints in Global Market
Table 4. Key Players of Molecular Diagnosis and Therapy in Global Market
Table 5. Top Molecular Diagnosis and Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Molecular Diagnosis and Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Molecular Diagnosis and Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Molecular Diagnosis and Therapy Product Type
Table 9. List of Global Tier 1 Molecular Diagnosis and Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Molecular Diagnosis and Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Molecular Diagnosis and Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Molecular Diagnosis and Therapy Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Molecular Diagnosis and Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Molecular Diagnosis and Therapy Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Molecular Diagnosis and Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Molecular Diagnosis and Therapy Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2024-2032
Table 30. Abbott Laboratories Company Summary
Table 31. Abbott Laboratories Molecular Diagnosis and Therapy Product Offerings
Table 32. Abbott Laboratories Molecular Diagnosis and Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Abbott Laboratories Key News & Latest Developments
Table 34. Agilent Technologies Company Summary
Table 35. Agilent Technologies Molecular Diagnosis and Therapy Product Offerings
Table 36. Agilent Technologies Molecular Diagnosis and Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Agilent Technologies Key News & Latest Developments
Table 38. Becton, Dickinson and Company Company Summary
Table 39. Becton, Dickinson and Company Molecular Diagnosis and Therapy Product Offerings
Table 40. Becton, Dickinson and Company Molecular Diagnosis and Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Becton, Dickinson and Company Key News & Latest Developments
Table 42. Biom?rieux Sa Company Summary
Table 43. Biom?rieux Sa Molecular Diagnosis and Therapy Product Offerings
Table 44. Biom?rieux Sa Molecular Diagnosis and Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Biom?rieux Sa Key News & Latest Developments
Table 46. Danaher Corporation Company Summary
Table 47. Danaher Corporation Molecular Diagnosis and Therapy Product Offerings
Table 48. Danaher Corporation Molecular Diagnosis and Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Danaher Corporation Key News & Latest Developments
Table 50. Diasorin Company Summary
Table 51. Diasorin Molecular Diagnosis and Therapy Product Offerings
Table 52. Diasorin Molecular Diagnosis and Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Diasorin Key News & Latest Developments
Table 54. Grifols Company Summary
Table 55. Grifols Molecular Diagnosis and Therapy Product Offerings
Table 56. Grifols Molecular Diagnosis and Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Grifols Key News & Latest Developments
Table 58. Hologic Company Summary
Table 59. Hologic Molecular Diagnosis and Therapy Product Offerings
Table 60. Hologic Molecular Diagnosis and Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Hologic Key News & Latest Developments
Table 62. Illumina Company Summary
Table 63. Illumina Molecular Diagnosis and Therapy Product Offerings
Table 64. Illumina Molecular Diagnosis and Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Illumina Key News & Latest Developments
Table 66. Qiagen Company Summary
Table 67. Qiagen Molecular Diagnosis and Therapy Product Offerings
Table 68. Qiagen Molecular Diagnosis and Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Qiagen Key News & Latest Developments
Table 70. Roche Diagnostics Company Summary
Table 71. Roche Diagnostics Molecular Diagnosis and Therapy Product Offerings
Table 72. Roche Diagnostics Molecular Diagnosis and Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. Roche Diagnostics Key News & Latest Developments
Table 74. Siemens AG Company Summary
Table 75. Siemens AG Molecular Diagnosis and Therapy Product Offerings
Table 76. Siemens AG Molecular Diagnosis and Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. Siemens AG Key News & Latest Developments
Table 78. Thermo Fisher Scientific Company Summary
Table 79. Thermo Fisher Scientific Molecular Diagnosis and Therapy Product Offerings
Table 80. Thermo Fisher Scientific Molecular Diagnosis and Therapy Revenue (US$, Mn) & (2018-2023)
Table 81. Thermo Fisher Scientific Key News & Latest Developments
List of Figures
Figure 1. Molecular Diagnosis and Therapy Segment by Type in 2022
Figure 2. Molecular Diagnosis and Therapy Segment by Application in 2022
Figure 3. Global Molecular Diagnosis and Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Molecular Diagnosis and Therapy Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Molecular Diagnosis and Therapy Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Molecular Diagnosis and Therapy Revenue in 2022
Figure 8. By Type - Global Molecular Diagnosis and Therapy Revenue Market Share, 2018-2032
Figure 9. By Application - Global Molecular Diagnosis and Therapy Revenue Market Share, 2018-2032
Figure 10. By Type - Global Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Molecular Diagnosis and Therapy Revenue Market Share, 2018-2032
Figure 12. By Application - Global Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Molecular Diagnosis and Therapy Revenue Market Share, 2018-2032
Figure 14. By Region - Global Molecular Diagnosis and Therapy Revenue Market Share, 2018-2032
Figure 15. By Country - North America Molecular Diagnosis and Therapy Revenue Market Share, 2018-2032
Figure 16. US Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Molecular Diagnosis and Therapy Revenue Market Share, 2018-2032
Figure 20. Germany Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2018-2032
Figure 21. France Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Molecular Diagnosis and Therapy Revenue Market Share, 2018-2032
Figure 28. China Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2018-2032
Figure 32. India Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Molecular Diagnosis and Therapy Revenue Market Share, 2018-2032
Figure 34. Brazil Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Molecular Diagnosis and Therapy Revenue Market Share, 2018-2032
Figure 37. Turkey Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Molecular Diagnosis and Therapy Revenue, (US$, Mn), 2018-2032
Figure 41. Abbott Laboratories Molecular Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Agilent Technologies Molecular Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Becton, Dickinson and Company Molecular Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Biom?rieux Sa Molecular Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Danaher Corporation Molecular Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Diasorin Molecular Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Grifols Molecular Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Hologic Molecular Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Illumina Molecular Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Qiagen Molecular Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Roche Diagnostics Molecular Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Siemens AG Molecular Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Thermo Fisher Scientific Molecular Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
